Enhancement of natural killer-cell activity in young and old mice treated with cyclophosphamide on a circadian basis.

L. E. Sandberg, G. Fernandes

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Several recent studies have revealed a significant circadian variation in immunological functions including natural killer (NK)-cell activity against tumor target cells both in rodents and in man. We have previously reported circadian changes in antibody-forming cells as well as NK-cell activity in mice and rats. The present study was undertaken to determine the effect of high and low doses of cyclophosphamide on circadian NK-cell activity in young (8-week-old) and old (8-month-old) female C57BL/6 (B/6) mice. The results revealed that, in general, young animals had higher NK activity than old animals. In both young and old mice, the high dose of cyclophosphamide depressed NK activity. In contrast, the low dose of cyclophosphamide showed significantly increased NK activity, which was proportionately greater in old mice than in young mice. Cyclophosphamide-enhanced NK activity was found to be higher during the resting period than during periods of activity. Apparently, high NK activity can be induced with a circadian-based immunotherapy regime using low-dose cyclophosphamide in both young and old animals. It is presently not clear if increased NK activity caused by cyclophosphamide is due to a decrease in activity of immunoregulatory cells, such as T cells, B cells, or macrophages. More studies are required to determine the basis of increased NK activity caused by treatment with low dosages of cyclophosphamide in mice.

Original languageEnglish (US)
Pages (from-to)411-419
Number of pages9
JournalProgress in Clinical and Biological Research
Volume227 A
StatePublished - 1987
Externally publishedYes

Fingerprint

Natural Killer Cells
Cyclophosphamide
Immunotherapy
Rodentia
B-Lymphocytes
Macrophages
T-Lymphocytes
Antibodies
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Enhancement of natural killer-cell activity in young and old mice treated with cyclophosphamide on a circadian basis. / Sandberg, L. E.; Fernandes, G.

In: Progress in Clinical and Biological Research, Vol. 227 A, 1987, p. 411-419.

Research output: Contribution to journalArticle

@article{821d076c3c7c476fadf7f08d187a2d86,
title = "Enhancement of natural killer-cell activity in young and old mice treated with cyclophosphamide on a circadian basis.",
abstract = "Several recent studies have revealed a significant circadian variation in immunological functions including natural killer (NK)-cell activity against tumor target cells both in rodents and in man. We have previously reported circadian changes in antibody-forming cells as well as NK-cell activity in mice and rats. The present study was undertaken to determine the effect of high and low doses of cyclophosphamide on circadian NK-cell activity in young (8-week-old) and old (8-month-old) female C57BL/6 (B/6) mice. The results revealed that, in general, young animals had higher NK activity than old animals. In both young and old mice, the high dose of cyclophosphamide depressed NK activity. In contrast, the low dose of cyclophosphamide showed significantly increased NK activity, which was proportionately greater in old mice than in young mice. Cyclophosphamide-enhanced NK activity was found to be higher during the resting period than during periods of activity. Apparently, high NK activity can be induced with a circadian-based immunotherapy regime using low-dose cyclophosphamide in both young and old animals. It is presently not clear if increased NK activity caused by cyclophosphamide is due to a decrease in activity of immunoregulatory cells, such as T cells, B cells, or macrophages. More studies are required to determine the basis of increased NK activity caused by treatment with low dosages of cyclophosphamide in mice.",
author = "Sandberg, {L. E.} and G. Fernandes",
year = "1987",
language = "English (US)",
volume = "227 A",
pages = "411--419",
journal = "Progress in Clinical and Biological Research",
issn = "0361-7742",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Enhancement of natural killer-cell activity in young and old mice treated with cyclophosphamide on a circadian basis.

AU - Sandberg, L. E.

AU - Fernandes, G.

PY - 1987

Y1 - 1987

N2 - Several recent studies have revealed a significant circadian variation in immunological functions including natural killer (NK)-cell activity against tumor target cells both in rodents and in man. We have previously reported circadian changes in antibody-forming cells as well as NK-cell activity in mice and rats. The present study was undertaken to determine the effect of high and low doses of cyclophosphamide on circadian NK-cell activity in young (8-week-old) and old (8-month-old) female C57BL/6 (B/6) mice. The results revealed that, in general, young animals had higher NK activity than old animals. In both young and old mice, the high dose of cyclophosphamide depressed NK activity. In contrast, the low dose of cyclophosphamide showed significantly increased NK activity, which was proportionately greater in old mice than in young mice. Cyclophosphamide-enhanced NK activity was found to be higher during the resting period than during periods of activity. Apparently, high NK activity can be induced with a circadian-based immunotherapy regime using low-dose cyclophosphamide in both young and old animals. It is presently not clear if increased NK activity caused by cyclophosphamide is due to a decrease in activity of immunoregulatory cells, such as T cells, B cells, or macrophages. More studies are required to determine the basis of increased NK activity caused by treatment with low dosages of cyclophosphamide in mice.

AB - Several recent studies have revealed a significant circadian variation in immunological functions including natural killer (NK)-cell activity against tumor target cells both in rodents and in man. We have previously reported circadian changes in antibody-forming cells as well as NK-cell activity in mice and rats. The present study was undertaken to determine the effect of high and low doses of cyclophosphamide on circadian NK-cell activity in young (8-week-old) and old (8-month-old) female C57BL/6 (B/6) mice. The results revealed that, in general, young animals had higher NK activity than old animals. In both young and old mice, the high dose of cyclophosphamide depressed NK activity. In contrast, the low dose of cyclophosphamide showed significantly increased NK activity, which was proportionately greater in old mice than in young mice. Cyclophosphamide-enhanced NK activity was found to be higher during the resting period than during periods of activity. Apparently, high NK activity can be induced with a circadian-based immunotherapy regime using low-dose cyclophosphamide in both young and old animals. It is presently not clear if increased NK activity caused by cyclophosphamide is due to a decrease in activity of immunoregulatory cells, such as T cells, B cells, or macrophages. More studies are required to determine the basis of increased NK activity caused by treatment with low dosages of cyclophosphamide in mice.

UR - http://www.scopus.com/inward/record.url?scp=0023087316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023087316&partnerID=8YFLogxK

M3 - Article

C2 - 3601975

AN - SCOPUS:0023087316

VL - 227 A

SP - 411

EP - 419

JO - Progress in Clinical and Biological Research

JF - Progress in Clinical and Biological Research

SN - 0361-7742

ER -